PUBLISHER: Grand View Research | PRODUCT CODE: 1654194
PUBLISHER: Grand View Research | PRODUCT CODE: 1654194
The global duodenal ulcer treatment market size is anticipated to reach USD 5.54 billion in 2030 and is anticipated to grow at a CAGR of 3.2% from 2025 to 2030. The market encompasses a range of elements focused on the management and treatment of duodenal ulcers, which are sores that occur in the lining of the duodenum.
Pharmacological treatments are crucial to the duodenal ulcer treatment market. These medications include proton pump inhibitors (PPIs), histamine receptor antagonists (H2RAs), and antibiotics targeting Helicobacter pylori infections, mucosal protectants, and antacids. These medications reduce gastric acid production, eradicate bacterial pathogens, enhance mucosal defense, or neutralize stomach acid. This therapeutic approach alleviates bloating, abdominal pain, and discomfort while accelerating ulcer healing.
The market is experiencing significant growth due to the incorporation of digital health solutions such as mobile apps, telemedicine platforms, and remote monitoring tools. These technologies enable personalized treatment management, real-time symptom tracking, and enhanced patient engagement. Additionally, artificial intelligence (AI) algorithms are being employed to analyze large datasets, which improves treatment outcomes and facilitates early detection of ulcer issues.